TY - JOUR
T1 - Consensus Statement for the Management and Treatment of Port-Wine Birthmarks in Sturge-Weber Syndrome
AU - Sabeti, Sara
AU - Ball, Karen L.
AU - Burkhart, Craig
AU - Eichenfield, Lawrence
AU - Fernandez Faith, Esteban
AU - Frieden, Ilona J.
AU - Geronemus, Roy
AU - Gupta, Deepti
AU - Krakowski, Andrew C.
AU - Levy, Moise L.
AU - Metry, Denise
AU - Nelson, J. Stuart
AU - Tollefson, Megha M.
AU - Kelly, Kristen M.
N1 - Funding Information:
reported receiving grants from the Sturge-Weber Foundation during the conduct of the study. Dr Frieden reported receiving personal fees from Pfizer, Venthera Biobridge, Nobel Pharmaceuticals, and Novartis outside the submitted work. Dr Kelly reported receiving personal fees from IQVIA, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd, and Sciton; grants and other support from Sturge-Weber Foundation; nonfinancial support from Michaelson Diagnostics; and grants and other support from Allergan during the conduct of the study; other support from R2Derm outside the submitted work; and serving as an unpaid board member for the American Society for Laser Medicine and Surgery. No other disclosures were reported.
Publisher Copyright:
© 2021 American Medical Association. All rights reserved.
PY - 2021/1
Y1 - 2021/1
N2 - Importance: Sturge-Weber syndrome (SWS) is a neurocutaneous syndrome involving the skin, brain, and eyes. Consensus recommendations for management are lacking. Objective: To consolidate the current literature with expert opinion to make recommendations that will guide treatment and referral for patients with port-wine birthmarks (PWBs). Evidence Review: In this consensus statement, 12 nationally peer-recognized experts in dermatology with experience treating patients with SWS were assembled. Key topics and questions were formulated for each group and included risk stratification, optimum treatment strategies, and recommendations regarding light-based therapies. A systematic PubMed search was performed of English-language articles published between December 1, 2008, and December 1, 2018, as well as other pertinent studies identified by the expert panel. Clinical practice guidelines were recommended. Findings: Treatment of PWBs is indicated to minimize the psychosocial impact and diminish nodularity and potentially tissue hypertrophy. Better outcomes may be attained if treatments are started at an earlier age. In the US, pulsed dye laser is the standard for all PWBs regardless of the lesion size, location, or color. When performed by experienced physicians, laser treatment can be safe for patients of all ages. The choice of using general anesthesia in young patients is a complex decision that must be considered on a case-by-case basis. Conclusions and Relevance: These recommendations are intended to help guide clinical practice and decision-making for patients with SWS and those with isolated PWBs and may improve patient outcomes..
AB - Importance: Sturge-Weber syndrome (SWS) is a neurocutaneous syndrome involving the skin, brain, and eyes. Consensus recommendations for management are lacking. Objective: To consolidate the current literature with expert opinion to make recommendations that will guide treatment and referral for patients with port-wine birthmarks (PWBs). Evidence Review: In this consensus statement, 12 nationally peer-recognized experts in dermatology with experience treating patients with SWS were assembled. Key topics and questions were formulated for each group and included risk stratification, optimum treatment strategies, and recommendations regarding light-based therapies. A systematic PubMed search was performed of English-language articles published between December 1, 2008, and December 1, 2018, as well as other pertinent studies identified by the expert panel. Clinical practice guidelines were recommended. Findings: Treatment of PWBs is indicated to minimize the psychosocial impact and diminish nodularity and potentially tissue hypertrophy. Better outcomes may be attained if treatments are started at an earlier age. In the US, pulsed dye laser is the standard for all PWBs regardless of the lesion size, location, or color. When performed by experienced physicians, laser treatment can be safe for patients of all ages. The choice of using general anesthesia in young patients is a complex decision that must be considered on a case-by-case basis. Conclusions and Relevance: These recommendations are intended to help guide clinical practice and decision-making for patients with SWS and those with isolated PWBs and may improve patient outcomes..
UR - http://www.scopus.com/inward/record.url?scp=85096121870&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85096121870&partnerID=8YFLogxK
U2 - 10.1001/jamadermatol.2020.4226
DO - 10.1001/jamadermatol.2020.4226
M3 - Review article
C2 - 33175124
AN - SCOPUS:85096121870
SN - 2168-6068
VL - 157
SP - 98
EP - 104
JO - JAMA Dermatology
JF - JAMA Dermatology
IS - 1
ER -